Understanding Axitinib 5 mg Tablet in the Treatment of Renal Cell Carcinoma (RCC)
Axitinib 5 mg blocks VEGF receptors to limit blood vessel growth in advanced kidney cancer. Learn how it may be used alone or with immunotherapy and what side effects to monitor.
